显微浸润在临床靶体积定义中的研究进展  

Research progress on microscopic extension in defining clinical target volume

作　　者：王晓航[1] 耿建昊 张丝媛[1] 朱向高[1] 王维虎 Wang Xiaohang;Geng Jianhao;Zhang Siyuan;Zhu Xianggao;Wang Weihu(Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital and Institute,Beijing 100142,China)

机构地区：[1]北京大学肿瘤医院暨北京市肿瘤防治研究所放疗科恶性肿瘤发病机制及转化研究教育部重点实验室,100142

出　　处：《中华放射肿瘤学杂志》2020年第9期809-812,共4页Chinese Journal of Radiation Oncology

基　　金：北京市医管局扬帆计划(XMLX201842);北京市自然科学基金(7182028)。

摘　　要：显微浸润(亚临床病变)的范围是放疗临床靶体积定义的关键因素。本文将分别针对食管癌、肺癌、肝癌、前列腺癌、膀胱癌、直肠癌、乳腺癌、非黑色素瘤皮肤癌以及转移淋巴结的显微浸润/包膜外侵的研究结果进行综述。这些研究结果为临床靶体积的定义提供了重要的依据,但仍有许多问题值得进一步探索。Microscopic extension(subclinical lesion)is the key factor for defining clinical target volume in radiotherapy.In this article,the research progresses on microscopic extension or extracapsular extension in esophageal cancer,lung cancer,hepatocellular carcinoma,prostate cancer,bladder cancer,rectal cancer,breast cancer,non-melanoma skin cancer and metastatic lymph nodes were reviewed.These results provide important basis for the definition of clinical target volume.However,a series of questions remain to be properly resolved.

关 键 词：显微浸润 肿瘤 包膜外侵 肿瘤 临床靶体积 放射疗法 

分 类 号：R730.55[医药卫生—肿瘤]